#Abbott diagnostics analyst reports full
(You can read the full research report on ServiceNow here >) Strategic alliances with the likes of Microsoft remain tailwinds.
#Abbott diagnostics analyst reports upgrade
As businesses, government agencies and others continue to upgrade their infrastructure to cloud, the company is poised to boost uptake of its Now platform.įurther, its expanding global presence, solid partner base and strategic buyouts are expected to bolster growth prospects. The company is riding on the increasing adoption of its workflows by enterprises undergoing digital transformation. However, robust growth in subscription revenues as reflected by the strong third-quarter 2022 results. Stiff competition is a headwind and is expected to hurt prospects in the long haul. The company is suffering from high inflation, unfavorable forex and challenging macro-economic environment. Shares of ServiceNow have underperformed the Zacks Computers - IT Services industry over the past year (-39.1% vs. (You can read the full research report on Abbott Laboratories here >) Abbott exited the third quarter of 2022 with better-than-expected earnings and revenues. Meanwhile, the Diabetes Care business continued to benefit from the growing sales of its flagship CGM system, FreeStyle Libre. The company's total sales were negatively impacted by COVID-19 testing-related sales decline and a manufacturing stoppage initiated in February of certain infant nutrition formula products manufactured at Abbott's Sturgis, MI, facility.Įxcluding these negative factors, total worldwide sales increased 6% on an organic basis, benefiting from robust sales growth across the company's core Established Pharmaceuticals and Medical Devices segments. You can see all of today's research reports here >Ībbott Laboratories' shares have declined -22.2% over the past year against the Zacks Medical - Products industry's decline of -49.3%. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today. Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories, ServiceNow, Inc.
The Zacks Research Daily presents the best research output of our analyst team. Here are highlights from Wednesday’s Analyst Blog: Top Research Reports for Abbott Labs, ServiceNow and Schlumberger Stocks recently featured in the blog include: Abbott Laboratories ABT, ServiceNow, Inc. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Chicago, IL – Novem– announces the list of stocks featured in the Analyst Blog.
0 kommentar(er)
